This year sees the International Symposium on ALS/MND, organized by the Motor Neurone Disease Association, UK in collaboration with the International Alliance of ALS/MND Associations, return to Australia for the first time in almost a decade. We are welcomed to Sydney by our hosts at MND Australia, in partnership with MND New South Wales.
Under the leadership of their chair Prof Wim Robberecht, the Symposium Programme Committee has compiled a stimulating and varied platform programme. The meeting opens and closes with joint plenary sessions that reflect the emergence of new understanding of disease mechanisms and therapy development. The parallel scientific and clinical sessions go on to explore a wide variety of pertinent themes in more depth, from target pathways, disease models and biomarkers, through to clinical trials, holistic care and the development of practice guidelines. The programme also offers plenty of new perspectives, with key insights from other neurodegenerative diseases, a fresh look at the BMAA story and a truly international offering of care practice findings.
Once again this year, the quality and quantity of the poster presentations promise plenty of lively discussion and debate across the two dedicated poster sessions and beyond, furthering the international exchange of knowledge.
Research Development Team
Motor Neurone Disease Association, Northampton, UK